GreenLight Clinical

🎉 Happy Thanksgiving! 🍂 As we gather around the table this holiday season, we want to take a moment to express our heartfelt gratitude to all our incredible collaborators. Your hard work, dedication, and creativity have been vital to our journey, and we truly appreciate each and every one of you. This special day reminds us of the importance of #community and partnership, and we are truly thankful for the incredible relationships we've built with each of you. Thank you for your unwavering support, innovative ideas, and the positive energy you bring to our projects. Together, we have achieved so much, and it’s a pleasure to celebrate this season of thankfulness with all of you. Thank you for being a vital part of our journey — we look forward to sharing many more successes together in the future! Wishing you and your loved ones a joyful and peaceful Thanksgiving! 🦃✨ #GreenLightClinical #Thanksgiving

We were honoured to host a delegation from Wenzhou Municipal Science and Technology Bureau, China at GreenLight Clinical’s headquarters, Sydney. Wenzhou Science and Technology Bureau is responsible for the implementation of its innovation development strategy, formulate plans and policies for the city's sci-tech development and foreign talent introduction, and organise their implementation. Their visit marks a significant step in strengthening global partnership to advance innovation in clinical research and development.   GreenLight Clinical (GLC) is a strategic collaboration partner of Wenzhou Eye Valley, aligned with the initiatives of the Wenzhou Municipal #Science and Technology Bureau. The director of the Bureau visited GLC to further enhance our collaboration and provide their support. Together we aim to accelerate therapies that transform lives.   A big thank you to members of Wenzhou delegation for their insights and collaborative spirit: Xiang Xiaodong, Deputy Director, Wenzhou Science and Technology Bureau Wu Mingfeng, Director, Wenzhou Bay New Area Science and Talent Bureau Shi Xiaowei, Dean, Wenzhou Science and Technology Information Research Institute Hao Xiaojuan, Researcher, National Institute of Science and Technology, Wenzhou Huang Yongda, Chairman, Zhejiang Yuzhan Information Technology Co., Ltd. Su Lingping, Executive Vice President, Wenzhou Haihe Pharmaceutical Co., Ltd. Jin Weiwei, General Manager, Wenzhou Ruijing Technology Co., Ltd.   A heartfelt thank you to our CEO, Dr Robert Lin, MBA and Chief Medical Advisor, Dr. Meidong Zhu for championing this meaningful meeting with Wenzhou Science and Technology Bureau. Your vision for global partnerships for advancing #innovation inspires us all. #GreenLightClinical #ClinicalResearch #Ophthalmology

WHO Cervical Cancer Elimination Day of Action 2024 is observed on 17th November. Today, we recognise the critical contributions of frontline health workers in the fight against cervical cancer. Cervical cancer is a significant health issue affecting women worldwide, primarily caused by persistent infection with high-risk strains of the human papillomavirus (HPV). Fortunately, Australia has an active screening test and vaccine programme for cervical cancer, which ensures that Australia has one of the lowest rates of cervical cancer in the world. Unfortunately, not all countries have such a screening and vaccination programme in place. In order to reduce the prevalence of cervical cancer, the World Health Organization has set the following goals: ✔ 90% of girls fully vaccinated with HPV vaccine by age 15 years ✔70% of women are screened with a high-performance test by 35 years of age and again by 45 years of age ✔90% of women identified with cervical disease receive treatment (90% of women with precancer treated, and 90% of women with invasive cancer managed). Raising awareness about risk factors, symptoms, and the importance of screening is crucial to combating this disease. GreenLight Clinical (GLC), as a CRO, is committed to advancing healthcare with global efforts to eliminate cervical cancer. Please join us in supporting cervical cancer prevention. Let's empower women to take charge of their health and advocate for increased access to education and healthcare resources. #CervicalCancer #GreenLightClinical #ClinicalTrial #MedicalAffairs

November 14 has been chosen as World Diabetes Day to raise awareness of this debilitating disease. The incidence of #diabetes has been steadily increasing globally, particularly with increased obesity and metabolic syndrome associated with poor eating habits and a sedentary lifestyle. Besides complications with wound healing and increased risk of infections, eye health is severely impacted. Conditions such as diabetic retinopathy, diabetic macular oedema, cataracts, and glaucoma are frequently found in diabetics and can lead to irreversible blindness. If you have diabetes or are at risk of developing diabetes, now is a good opportunity to see your eye doctor for a routine exam. At GreenLight Clinical, we have been driven by a passion for advances in ocular medicine and treatments. Our team of experts has over 70 cumulative years of experience in ophthalmology clinical trials and are ready to help you through your clinical trial journey. You can learn more about us at www.greenlightclinical.com #GreenLightClincial #WorldDiabetesDay #Ophthalmology #clinicaltrials

As we are wrapping up #AusBiotech Day 3, we thank everyone who stopped by and met us at our booth. We are inspired by the enthusiasm and dedication shown by our partners and potential collaborators. We are excited about the future and helping to bring new and life-changing products to the clinic and beyond. Please reach out to us at www.greenlightclinical.com to discover how we can help you with your #innovation. #GreenLightClinical

Day 2 at #AusBiotech'24 has been productive! Today, we focused on collaboration. We are eager to continue these conversations on Day 3 & shape impactful solutions that drive the clinical research. We are at Booth 17. Please come and say hello👋 With our vast network of clinical trial sites and specialised clinicians in ophthalmology, oncology, and gene & stem cell therapies we are here to help bring your research to life. #GreenLightClinical #Collaboration

Day 1 at #AusBiotech'24 is here, and we're thrilled to kick-off an incredible 3 days of #networking. 🚀 Our team is ready to connect with industry leaders and biotech innovators. Stop by & say hello 👋– let’s make this AusBiotech'24 a memorable one together! #GreenLightClinical #collaboration

Looking forward to connecting with everyone tomorrow at AusBiotech'24! Excited to explore new opportunities, build partnerships, and share insights with industry leaders and innovators. Let's make it a memorable and productive event! See you there at Booth 17! #AusBiotech #Collaboration #Innovation #GreenLightClinical

#regulatory#biotech#greenlight

🌟 Strategic Partnership to Advance Ophthalmic Research & Innovation🌟   We are excited to announce that GreenLight Clinical (GLC) has entered into a strategic cooperation agreement with Eye Valley, the only Visual Industry Innovation Complex in China, to accelerate ophthalmology research and development between Australia and China. This milestone would not have been possible without the incredible effort of Dr. Robert Lin, CEO of GLC, Dr Meidong Zhu, CMO of GLC, and Prof. Liangde Xu, Prof. Hong Wang, and Dr. Zhenzhen Lu from Eye Valley and Wenzhou Medical University. The newly established state-of-the-art Eye Valley complex promotes advancement in eye care and vision health, and brings together renowned research professionals in the fields of ophthalmology, drug development and delivery, optical equipment, ophthalmic smart healthcare, and future technologies. Eye Valley is at the forefront of developing cutting edge ophthalmic treatments by transforming scientific discoveries into practical applications. This strategic agreement is a recognition of GLC’s expertise and capabilities in the field of ophthalmology and clinical trials, highlighting that GLC is the preeminent Australian CRO for #ophthalmology. This partnership represents a significant leap ahead for both GLC and Eye Valley in ophthalmology research and development, combining global expertise and resources to shape the future of eye health. Read more about GLC (www.greenlightclinical.com) and Eye Valley (https://lnkd.in/gQRvhjRy). #GreenLightClinical #Collaboration #ClinicalResearch #Innovation